BlueInGreen Uses Wastewater Treatment Technology to Fight COVID-19

With workers, communities and corporations around the globe joining the battle against COVID-19, one company is attacking the virus from an unexpected angle: water.

VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact

Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic...

From The Corner Office: SFC Fluidics Nears FDA Submission

“Did you eat too much candy as a child?” “You don’t look diabetic…you are not at all overweight.” “You just have to watch your sugar intake, right?” These are typical, insensitive comments that people with diabetes...

VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics

Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic events such as stroke

VIC Launches New Fellows Program

The VIC Fellows Program was created as a mechanism through which individuals with specific expertise can learn about and be involved in the process of identifying and evaluating promising life science innovation from...

VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

An Interview with Darlene Boudreaux: CEO, Investor, and Entrepreneur

Can you tell us a little bit about your background and experience? I was a founder and CEO of a pharmaceutical manufacturing company, and then took over and grew a nonprofit medical technology incubator, helping others...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

Behind the Curtain with Biolocity | Guiding Medical Innovations to Market

Please start off by describing your current role with Biolocity and the organization’s unique model.  I am the Managing Director for Biolocity, which is a philanthropic, multi-institutional program that accelerates the...

FEATURED RESOURCES

News
VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics
Case Study
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
Reports
VIC 2019 Annual Report
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
News
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Interview
An Interview with Nichole Mercier at Washington University
White Paper
Sourcing Quality Innovation Beyond the VC Hot Zones
Case Study
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
White Paper
New Paradigms of Life Science Investing
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
News
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
White Paper
Life Science Impact Investing and the Physician Entrepreneur
From The Corner Office
SFC Fluidics Nears FDA Submission